EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Psychopathology and Psychiatric Risks Linked to High-Potency Cannabis, Crack Cocaine and Novel Psychoactive Substances

Tommaso Piro, Alessia Santeusanio, Federica Marsico, Arianna Rosati, Andrea Miuli, John Martin Corkery, Giovanni Martinotti

Clinical Neuropsychopharmacology and Addiction · 2025

DOI: 10.53941/cna.2025.100008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Neuropsychopharmacology and Addiction, 2025. Verfasst von Tommaso Piro und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High potency cannabis (HPC), crack cocaine, and novel psychoactive substances (NPS) have significantly reshaped the landscape of substance-related psychopathology. This transformation is driven both by the increased psychoactive potency of known substances and by the emergence of new synthetic compounds. The aim of this paper is to provide a practical clinical reference for settings lacking laboratory support.

Methods

This study analyzes 69 articles published between 2015 and 2025, encompassing a total of 126,365 patients reporting symptoms associated with the use of HPC, crack, and NPS.

Results

HPC is associated with an increased risk of acute and persistent psychosis, seems proportional link to THC concentration. Synthetic cannabinoids are also frequently associated with acute psychosis, hallucinations, and delusions. Cathinones are associated with psychotic symptomatology, while crack cocaine is primarily linked to mood disorders, depressive symptomatology, and suicidality.

Discussion

Increasing THC concentrations in HPC appear to be associated with more severe psychotic manifestations, such as paranoia, aggression, and hallucinations. Synthetic cannabinoids can trigger auditory and visual hallucinations, underlining that stimulation of the endocannabinoid system can elicit pronounced psychotic symptomatology. Cathinones are also associated with psychotic symptomatology, with a more heterogeneous presentation, but can additionally induce alterations of vital parameters and elevated Creatine Phosphokinase (CPK) levels. Depressive symptomatology is predominant in crack cocaine use, while all substances under review demonstrate an association with anxiety symptoms.

Conclusions

All three substance groups constitute a major and evolving challenge for mental health services. Distinctive symptom profiles can guide identification and evidence-based management in resource-limited settings.

Zitieren

APA

Piro, T., Santeusanio, A., Marsico, F., Rosati, A., Miuli, A., Corkery, J. M., & Martinotti, G. (2025). Psychopathology and Psychiatric Risks Linked to High-Potency Cannabis, Crack Cocaine and Novel Psychoactive Substances. Clinical Neuropsychopharmacology and Addiction. https://doi.org/10.53941/cna.2025.100008

Vancouver

Piro T, Santeusanio A, Marsico F, Rosati A, Miuli A, Corkery JM, et al. Psychopathology and Psychiatric Risks Linked to High-Potency Cannabis, Crack Cocaine and Novel Psychoactive Substances. Clinical Neuropsychopharmacology and Addiction. 2025. doi:10.53941/cna.2025.100008

BibTeX
@article{Piro2025,
  author = {Piro, Tommaso and Santeusanio, Alessia and Marsico, Federica and Rosati, Arianna and Miuli, Andrea and Corkery, John Martin and Martinotti, Giovanni},
  title = {Psychopathology and Psychiatric Risks Linked to High-Potency Cannabis, Crack Cocaine and Novel Psychoactive Substances},
  journal = {Clinical Neuropsychopharmacology and Addiction},
  year = {2025},
  doi = {10.53941/cna.2025.100008}
}
Kostenlos starten →